异动解读|金斯瑞生物科技盘中下跌3.14%,报35.16港元

行情直击
Aug 31

8月31日,金斯瑞生物科技盘中下跌3.14%,报35.16港元/股,成交额2.08亿港元。

金斯瑞生物科技所在的生命科学工具和服务行业中,个股涨跌分化,其中泰格医药涨11.26%,药明康德跌0.56%,药明合联跌0.89%,药明生物跌1.72%,英矽智能跌3.41%。

金斯瑞生物科技是一家主要从事生产及销售生命科学研究产品及服务的投资控股公司,业务涵盖生命科学服务及产品、生物制剂开发服务、工业合成生物产品及细胞疗法等板块,主要在中国国内和海外市场开展业务。

(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10